
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Nov 14, 2025 02:18 am UTC| Business Technology Science
Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Banks Seek Dismissal of Lawsuits Alleging They Enabled Jeffrey Epstein’s Trafficking
Nov 14, 2025 02:08 am UTC| Business Law Politics
Bank of America and Bank of New York Mellon have asked a federal judge to dismiss recently filed lawsuits accusing them of knowingly assisting Jeffrey Epsteins sex-trafficking activities by maintaining banking...

Ecopetrol Targets Strong 2025 Investment Execution Despite Profit Drop
Nov 14, 2025 02:06 am UTC| Business
Colombias state-run oil company Ecopetrol is preparing to close 2025 with a solid investment performance, projecting about $6.3 billion in executed spending, or roughly 90% of its annual target, according to company...

Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Nov 14, 2025 02:01 am UTC| Business Health
Merck is reportedly close to finalizing a deal to acquire Cidara Therapeutics, offering a premium over the biotechnology companys current market value of about $3.3 billion. According to a report from the Financial Times,...

Rio Tinto Boosts Renewable Energy Use with New Texas Wind Power Deal
Nov 14, 2025 01:56 am UTC| Business
Rio Tinto has expanded its clean-energy strategy with a new 15-year virtual power purchase agreement (VPPA) that will supply renewable electricity to its Kennecott copper operations in Utah. The agreement, signed with...

Under Armour and Stephen Curry End Longtime Partnership as Curry Brand Goes Independent
Nov 14, 2025 01:45 am UTC| Business
Under Armour and NBA superstar Stephen Curry have officially ended their long-running partnership, marking the close of a significant chapter for both the athlete and the sportswear company. Curry first joined Under Armour...

Pfizer Veteran Mikael Dolsten Withdraws From Novo Nordisk Board Consideration
Nov 14, 2025 01:43 am UTC| Business
Mikael Dolsten, the longtime Pfizer executive who led the companys research and development operations, has withdrawn his candidacy for a seat on Novo Nordisks board. Novo Nordisk confirmed on Thursday that Dolsten...